ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
CRISPR Therapeutics
The Scientist II will design and execute in‑vivo gene editing workflows, including cloning, primary cell work, ddPCR, and T‑cell phenotyping, while collaborating across teams to advance projects toward clinical readiness. The role requires strong molecular biology expertise, quantitative analysis skills, and the ability to manage multiple projects in a fast‑paced, innovative environment.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CRISPR Therapeutics.
72% above the average for this role
CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story
2 days ago
